FDA approves Tremfya for active Crohn's disease in adults
The U.S. Food and Drug Administration has approved Johnson & Johnson's Tremfya (guselkumab) for adult patients with ...
bne IntelliNews on MSN3d
Rights watchdog documents forced mobilisation of Central Asian labour migrants in Russian military
By Eurasianet Central Asian labour migrants in Russia have long been subjected to harassment and abuse at the hands of ...
Abivax Announces Full Year 2024 Financial Results
Abivax Announces Full Year 2024 Financial Results • Cash balance of EUR 144.2M as of December 31, 2024; cash runway into Q4 2025Full ...
EQS-News: Abivax Announces Full Year 2024 Financial Results
EQS-News: ABIVAX / Key word (s): Annual Results Abivax Announces Full Year 2024 Financial Results 24.03.2025 / 08:30 CET/CEST The issuer is solely responsible for the content of this announcement.